665 related articles for article (PubMed ID: 16469567)
1. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
2. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
4. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
J Urol; 2008 Jul; 180(1):99-103; discussion 103. PubMed ID: 18485415
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
[TBL] [Abstract][Full Text] [Related]
8. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
12. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
13. Extension of survival by resection of asynchronous renal cell carcinoma metastases to mediastinal lymph nodes.
Whitson BA; Groth SS; Andrade RS; Garrett L; Dudek AZ; Jessurun J; Maddaus MA
J Thorac Cardiovasc Surg; 2008 May; 135(5):1022-8. PubMed ID: 18455579
[TBL] [Abstract][Full Text] [Related]
14. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
[TBL] [Abstract][Full Text] [Related]
15. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
16. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
Hafez KS; Novick AC; Campbell SC
J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
Kuczyk M; Wegener G; Jonas U
Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
[TBL] [Abstract][Full Text] [Related]
18. Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
Delacroix SE; Chapin BF; Chen JJ; Nogueras-Gonzalez GM; Tamboli P; Matin SF; Wood CG
J Urol; 2011 Oct; 186(4):1236-41. PubMed ID: 21849197
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
Karakiewicz PI; Trinh QD; Bhojani N; Bensalah K; Salomon L; de la Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Schips L; Zigeuner R; Mulders PF; Valeri A; Descotes JL; Mejean A; Patard JJ
Eur Urol; 2007 Jun; 51(6):1616-24. PubMed ID: 17207909
[TBL] [Abstract][Full Text] [Related]
20. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]